Integral Diagnostics expands capital with new share quotation from dividend plan

Integral Diagnostics Limited (ASX:IDX) has applied for the quotation of 299,862 new ordinary fully paid securities. These additional securities, issued under a dividend or distribution plan, will rank equally with existing shares from their issue date of October 3, 2025. This move aims to expand the company's quoted capital.

The securities are being issued for a cash consideration, with an issue price of AUD 2.89074100 per security. The underlying dividend or distribution plan was lodged with the ASX on August 26, 2025. Following this quotation, Integral Diagnostics Limited's total ordinary fully paid securities on issue will increase to 372,926,663.

The application falls under an exception in Listing Rule 7.2, specifically exception 4, meaning it does not require security holder approval and the dividend or distribution plan does not impose a limit on participation.